Cullinan Therapeutics, Inc. · NASDAQ:CGEM

The Vanguard Group's stake in Cullinan Therapeutics, Inc. fell to 4.98% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Oct 30, 2025

The Vanguard Group's stake in Cullinan Therapeutics, Inc. fell to 4.98%, 2,943,325 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G/A).

Stake
4.98%
Shares
2,943,325
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
The Vanguard Group4.98%2,943,325

Source

View original at SEC

Related